Clinical Trials
3 trialsNCT06547476 2024-08-09
Chidamide and PD-1 Inhibitor Plus Anlotinib for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed
Guangdong Provincial People's Hospital
Phase 2 Not yet recruiting
NCT04734262 2023-11-18
SPARK
Fudan University
Phase 2 Unknown
NCT05861635 2023-05-17
The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4 Unknown